Giuseppe Morreale
Overview
Explore the profile of Giuseppe Morreale including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
332
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Giardino S, Faraci M, Lanino E, Morreale G, Terranova P, Palmisani E, et al.
Exp Clin Transplant
. 2017 Oct;
21(4):368-374.
PMID: 28969530
Dyskeratosis congenita is a rare congenital telomeropathy characterized by cutaneous and nail dystrophy, oral leukoplakia, and bone marrow failure. Pulmonary fibrosis and cancers are late manifestations. Allogeneic hematopoietic stem cell...
2.
Faraci M, Giardino S, Bagnasco F, Morreale G, Terranova M, Di Martino D, et al.
Pediatr Transplant
. 2017 Jun;
21(6).
PMID: 28649784
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the treatment of choice for a variety of congenital disorders. We report the experience of children affected by congenital diseases other than bone...
3.
Faraci M, Giardino S, Lanino E, Morreale G, Ghibaudo E, Francesia Berta M, et al.
J Pediatr Hematol Oncol
. 2017 Mar;
39(4):254-258.
PMID: 28267083
This study report clinical course, etiology, management, and long-term outcome of children who developed toxic epidermal necrolysis-like reaction (TEN-LR) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). We retrospectively collected children...
4.
Avanzini S, Mameli L, Disma N, Zanaboni C, Dato A, Montobbio G, et al.
Pediatr Blood Cancer
. 2016 Sep;
64(2):330-335.
PMID: 27578550
Background: Ultrasound-guided (USG) cannulation of the brachiocephalic vein (BCV) is gaining worldwide consensus for central venous access in children. This study reports a 20-month experience with this approach in children....
5.
Girardelli M, Arrigo S, Barabino A, Loganes C, Morreale G, Crovella S, et al.
BMC Pediatr
. 2015 Dec;
15:208.
PMID: 26671016
Background: Aggressive course and resistance to treatments usually characterize very early onset inflammatory bowel disease (VEO-IBD). Some VEO-IBD cases are due to monogenic immune defects and can benefit from hematopoietic...
6.
Faraci M, Matthes-Martin S, Lanino E, Morreale G, Ferretti M, Giardino S, et al.
Pediatr Transplant
. 2015 Nov;
20(1):158-61.
PMID: 26566972
POI is a relevant late complication after HSCT and occurring more frequently after MAC than after RIC regimens. Reports on the frequency of POI after RIC in a large pediatric...
7.
Fioredda F, Iacobelli S, van Biezen A, Gaspar B, Ancliff P, Donadieu J, et al.
Blood
. 2015 Jul;
126(16):1885-92.
PMID: 26185129
Allogeneic hematopoietic stem cell transplantation (HSCT) is the only curative treatment of severe congenital neutropenia (SCN), but data on outcome are scarce. We report on the outcome of 136 SCN...
8.
Giardino S, Lanino E, Morreale G, Madeo A, Di Rocco M, Gattorno M, et al.
Pediatrics
. 2014 Dec;
135(1):e211-5.
PMID: 25535259
Mevalonate kinase deficiency (MKD) is a rare autosomal recessive inborn error of metabolism with an autoinflammatory phenotype that may be expressed as a spectrum of disease phenotypes, from those with...
9.
Castagnola E, Bagnasco F, Bandettini R, Caviglia I, Morreale G, Lanino E, et al.
Biol Blood Marrow Transplant
. 2014 Apr;
20(7):1068-73.
PMID: 24691219
Data on epidemiology of severe infectious complications, ie, bacteremia or invasive fungal disease (IFD), in children with acute graft-versus-host disease (aGVHD) after allogeneic hemopoietic stem cell transplantation (HSCT) are scarce....
10.
Faraci M, Caviglia I, Biral E, Morreale G, Giardino S, Garbarino L, et al.
Pediatr Transplant
. 2012 Nov;
16(8):887-93.
PMID: 23131057
a-GvHD may complicate allogeneic HSCT. In this retrospective single-center study, we evaluated incidence and risk factors of a-GvHD in 197 consecutive allogeneic pediatric HSCTs applying Glucksberg and NIH a-GvHD classifications....